Molecules associated with fatty acid biosynthetic pathways and uses thereof
The present disclosure relates in part to recombinant microorganisms that include non-native genes encoding PUFA-PKS polypeptides, and to methods of making and using such microorganisms for producing at least one PUFA. In particular, the disclosure further relates to methods and related materials useful for the production of at least one PUFA by heterologous expression of the nucleic acid sequences disclosed herein encoding PUFA-PKS polypeptides.
1. A recombinant eukaryotic microorganism comprising at least one non-native nucleic acid sequence encoding a prokaryotic Type A polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) system comprising a pfaA gene, a pfaB gene, a pfaC gene, a pfaD gene, and a pfaE gene, wherein the pfaA gene encodes a polypeptide comprises comprising an amino acid sequence having at least 98% identity to SEQ ID NO:2,
the pfaB gene encodes a polypeptide comprises comprising an amino acid sequence having at least 96% identity to SEQ ID NO:4, the pfaC gene encodes a polypeptide comprises comprising an amino acid sequence having at least 98% identity to SEQ ID NO:6,
the pfaD gene encodes a polypeptide comprises comprising an amino acid sequence having at least 96% identity to SEQ ID NO:8, and
the pfaE gene encodes a polypeptide comprises comprising an amino acid sequence having at least 96% identity to SEQ ID NO: 10;
wherein the recombinant eukaryotic microorganism produces at least 50% more eicosapentaenoic acid (EPA) than a control eukaryotic microorganism.
2. A recombinant eukaryotic microorganism according to claim 1 , wherein the recombinant eukaryotic microorganism produces at least 75% more EPA than a control eukaryotic microorganism.
3. A recombinant eukaryotic microorganism according to claim 2 , wherein the eukaryotic microorganism produces at least 100% more EPA than a control eukaryotic microorganism.
4. A recombinant eukaryotic microorganism according to claim 1 , wherein the eukaryotic microorganism is a labyrinthulomycete.
5. A recombinant eukaryotic microorganism according to claim 4 , wherein the eukaryotic microorganism is of a genus selected from the group consisting of Aurantiochytrium, Oblongichytrium, Schizochytrium, Thraustochytrium , and Ulkenia.
6. A recombinant eukaryotic microorganism according to claim 1 , wherein the PUFA-PKS system is derived from a prokaryotic species of a genus selected from the group consisting of Shewanella, Vibrio, Aliivibrio, Pseudoaltermonas, Labyrinthuloides , and Psychromonas.
7. A recombinant eukaryotic microorganism according to claim 1 , wherein at least one non-native nucleic acid sequence is operably linked to a heterologous promoter.
8. A method for producing EPA, comprising culturing a recombinant eukaryotic microorganism according to claim 1 to produce EPA.
9. A method according to claim 8 , further comprising recovering EPA from the culture.
10. A method for according to claim 8 , wherein said culturing is performed at a temperature greater than 20° C.
11. A method for according to claim 10 , wherein said culturing is performed at a temperature greater than 25° C.
12. A method for according to claim 11 , wherein said culturing is performed at a temperature of at least 30° C.